195 related articles for article (PubMed ID: 34134639)
1. Cerebellar venous thrombosis mimicking a cerebellar tumor due to polycythemia vera: a case report.
Wen H; Jin D; Chen Y; Cui B; Xiao T
BMC Neurol; 2021 Jun; 21(1):225. PubMed ID: 34134639
[TBL] [Abstract][Full Text] [Related]
2. Combined venous and arterial thrombosis revealing underlying myeloproliferative disorder in a young patient: a case report.
Benmalek R; Mechal H; Zahidi H; Mounaouir K; Arous S; Benouna MEG; Drighil A; Habbal R
J Med Case Rep; 2021 Feb; 15(1):76. PubMed ID: 33593422
[TBL] [Abstract][Full Text] [Related]
3. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
[TBL] [Abstract][Full Text] [Related]
4. Risk of thrombosis in patients with essential thrombocythemia and polycythemia vera according to JAK2 V617F mutation status.
Finazzi G; Rambaldi A; Guerini V; Carobbo A; Barbui T
Haematologica; 2007 Jan; 92(1):135-6. PubMed ID: 17229651
[TBL] [Abstract][Full Text] [Related]
5. A new JAK2 gene mutation in patients with polycythemia vera and splanchnic vein thrombosis.
Colaizzo D; Amitrano L; Tiscia GL; Grandone E; Guardascione MA; Margaglione M
Blood; 2007 Oct; 110(7):2768-9. PubMed ID: 17881638
[No Abstract] [Full Text] [Related]
6. ST-Segment Elevation Myocardial Infarction and Bleeding Complications in JAK2-Negative Polycythemia.
Duran Luciano P; Sabella-Jiménez V
Tex Heart Inst J; 2023 Oct; 50(5):. PubMed ID: 37872693
[TBL] [Abstract][Full Text] [Related]
7. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
Iványi JL; Marton E; Plander M
Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
[TBL] [Abstract][Full Text] [Related]
8. The first report of a JAK2 V617F-positive myeloproliferative neoplasm with initial manifestation as a rare pampiniform venous plexus thrombosis and review of the literature.
Jacobs J; Sharma D; Vnencak-Jones C
J Thromb Thrombolysis; 2022 Jan; 53(1):213-217. PubMed ID: 34240279
[TBL] [Abstract][Full Text] [Related]
9. Should We Screen for Janus Kinase 2 V617F Mutation in Cerebral Venous Thrombosis?
Lamy M; Palazzo P; Agius P; Chomel JC; Ciron J; Berthomet A; Cantagrel P; Prigent J; Ingrand P; Puyade M; Neau JP
Cerebrovasc Dis; 2017; 44(3-4):97-104. PubMed ID: 28609766
[TBL] [Abstract][Full Text] [Related]
10. Central Nervous System Lymphoma Harboring the JAK2 V617F Mutation That Developed after a 20-year History of Polycythemia Vera.
Kajikawa N; Seki Y; Fujio T; Okoshi Y; Hori M; Saito H; Iijima T; Kojima H
Intern Med; 2018 Nov; 57(22):3293-3297. PubMed ID: 29984752
[TBL] [Abstract][Full Text] [Related]
11. Ischemic enteritis resulting from polycythemia vera.
Yagi S; Kioka K; Koizumi Y; Nakai T; Kawasaki Y; Tsutsumi M; Ishii N; Yamasaki T; Nebiki H; Maeda K
Clin J Gastroenterol; 2022 Oct; 15(5):907-912. PubMed ID: 35831680
[TBL] [Abstract][Full Text] [Related]
12. JAK2 exon 12 mutations in polycythemia vera or idiopathic erythrocytosis.
Martínez-Avilés L; Besses C; Alvarez-Larrán A; Cervantes F; Hernández-Boluda JC; Bellosillo B
Haematologica; 2007 Dec; 92(12):1717-8. PubMed ID: 18056003
[TBL] [Abstract][Full Text] [Related]
13. Cerebral venous thrombosis and myeloproliferative neoplasms: A three-center study of 74 consecutive cases.
Gangat N; Guglielmelli P; Betti S; Farrukh F; Carobbio A; Barbui T; Vannucchi AM; De Stefano V; Tefferi A
Am J Hematol; 2021 Dec; 96(12):1580-1586. PubMed ID: 34453762
[TBL] [Abstract][Full Text] [Related]
14. [Superior mesenteric and portal vein thrombosis in a polycythemia vera patient with JAK2 mutation].
Araki N; Takimoto R; Chiba H; Araki H; Sato T; Iyama S; Hirakawa M; Ono K; Kawano Y; Takada K; Miyanishi K; Kobune M; Matsunaga T; Kato J; Nakamura T; Niitsu Y
Rinsho Ketsueki; 2007 Jul; 48(7):554-8. PubMed ID: 17695304
[TBL] [Abstract][Full Text] [Related]
15. The role of JAK2 V617F mutation, spontaneous erythropoiesis and megakaryocytopoiesis, hypersensitive platelets, activated leukocytes, and endothelial cells in the etiology of thrombotic manifestations in polycythemia vera and essential thrombocythemia.
Bellucci S; Michiels JJ
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):381-98. PubMed ID: 16810614
[TBL] [Abstract][Full Text] [Related]
16. JAK2 mutation and acute coronary syndrome complicated with stent thrombosis.
Inami T; Okabe M; Matsushita M; Kobayashi N; Inokuchi K; Hata N; Seino Y; Shimizu W
Heart Vessels; 2016 Oct; 31(10):1714-6. PubMed ID: 26825737
[TBL] [Abstract][Full Text] [Related]
17. The relationship between factor V Leiden, prothrombin G20210A, and MTHFR mutations and the first major thrombotic episode in polycythemia vera and essential thrombocythemia.
Trifa AP; Cucuianu A; Popp RA; Coadă CA; Costache RM; Militaru MS; Vesa ŞC; Pop IV
Ann Hematol; 2014 Feb; 93(2):203-9. PubMed ID: 23828072
[TBL] [Abstract][Full Text] [Related]
18. The V617F mutation of JAK2 is very uncommon in patients with thrombosis.
Remacha AF; Estivill C; Sarda MP; Mateo J; Souto JC; Canals C; Nomdedéu J; Fontcuberta J
Haematologica; 2007 Feb; 92(2):285-6. PubMed ID: 17296594
[TBL] [Abstract][Full Text] [Related]
19. A Case of Recurrent Ischemic Stroke Involving Subacute, Progressive Intracranial Cerebral Arterial Sclerosis Prior to Diagnosis with JAK2-mutated Polycythemia Vera.
Nezu T; Aoki S; Ochi K; Sugihara S; Takahashi T; Hosomi N; Maruyama H; Matsumoto M
J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):e4-6. PubMed ID: 26432562
[TBL] [Abstract][Full Text] [Related]
20. JAK2 mutations across a spectrum of venous thrombosis cases.
Shetty S; Kulkarni B; Pai N; Mukundan P; Kasatkar P; Ghosh K
Am J Clin Pathol; 2010 Jul; 134(1):82-5. PubMed ID: 20551270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
